Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

515
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
515
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

249
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
249

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same author

Subclinical Primary Aldosteronism and eGFR Decline Over Time.

Journal of the American Society of Nephrology : JASN·2026
Same author

If You Prescribe It, Will They Come? An Initial Evaluation of a Hospital-Based Food Prescription Program in Under-Resourced Metabolic and Bariatric Surgery Patients With Food Insecurity.

American journal of lifestyle medicine·2025
Same author

Time to Acute Treatment in Intracerebral Hemorrhage Lags Significantly Behind Ischemic Stroke: A Multicenter, Observational Retrospective Study.

Stroke·2025
Same author

Gender-affirming Hormone Therapy and Changes in Kidney Function in Adults: A Retrospective Population-based Study.

Kidney medicine·2025
Same author

Robotic-assisted super-extended pelvic lymph node dissection for prostate cancer: safety and pathologic findings.

The Canadian journal of urology·2025

Related Experiment Video

Updated: Nov 12, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.3K

Does post prostatectomy decipher score predict biochemical recurrence and impact care?

Christine White1, Ilene Staff2, Tara McLaughlin3

  • 1Urology Division, Hartford Healthcare Medical Group, Hartford Hospital, 85 Seymour Street, Suite 416, Hartford, CT, 06106, USA.

World Journal of Urology
|March 20, 2021
PubMed
Summary
This summary is machine-generated.

The Decipher test accurately predicts early biochemical recurrence after prostate cancer surgery. High-risk Decipher scores can guide treatment decisions, potentially impacting patient outcomes.

Keywords:
GenomicsProstatectomyProstatic neoplasms

More Related Videos

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

66
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

934

Related Experiment Videos

Last Updated: Nov 12, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.3K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

66
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

934

Area of Science:

  • Oncology
  • Urology
  • Genomic Medicine

Background:

  • Radical prostatectomy is a primary treatment for prostate cancer.
  • Predicting biochemical recurrence after surgery is crucial for patient management.
  • The Decipher test offers genomic insights into prostate cancer aggressiveness.

Purpose of the Study:

  • To evaluate the Decipher test's ability to predict early biochemical recurrence post-radical prostatectomy.
  • To assess the Decipher test's impact on clinical decision-making before metastasis or death.

Main Methods:

  • Analysis of 203 Decipher tests ordered after radical prostatectomy for adverse pathology.
  • Kaplan-Meier and Cox regression analyses to correlate Decipher score with time to biochemical recurrence.
  • Secondary analysis in men with specific PSA levels to assess Decipher score association with salvage treatment.

Main Results:

  • Decipher score significantly predicted time to biochemical recurrence (p=0.027).
  • High-risk Decipher scores (≥0.60) were associated with salvage treatment (p=0.018).
  • Both stage and Decipher score predicted time to salvage treatment.

Conclusions:

  • The Decipher test demonstrates clinical utility in guiding prostate cancer treatment decisions.
  • While not always statistically significant, Decipher scores aid in patient management strategies.
  • Genomic profiling aids in personalized treatment approaches for prostate cancer.